Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease

Recruiting Observational Study
Chronic Liver Diseases Coagulation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
360 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic liver diseases represent a major public health problem and are responsible for more than 150,000 deaths in Europe each year. These diseases are accompanied by symptoms that profoundly alter the quality of life and mainly affect people of working age, leading to a major economic impact. Coagulation disorders, inflammation and vascular alterations are associated with chronic liver diseases …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients with chronic liver disease: Patients over 18 years of age Patients affiliated with a social security plan or entitled to receive benefits Patients with chronic liver disease or cirrhosis whose diagnosis is based on one or more of the following * Liver biopsy showing c…
Contacts

Pierre Emmanuel Rautou

140875283

pierre-emmanuel.rautou@aphp.fr

CONTACT

Alix Riescher-Tuczkiewicz

140875283

alix.riescher-tuczkiewicz@inserm.fr

CONTACT